Bioceramic Putty Versus MTA in Pulpotomized Primary Teeth to be Covered With 3D Printed Resin Crowns Versus Stainless Steel Crown

NCT ID: NCT07344038

Last Updated: 2026-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-20

Study Completion Date

2027-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

children aged 5 to 7 years with deep carious second primary molars that require vital pulp therapy will be treated using either MTA or bioceramic putty, then will be fully covered using either stainless steel crowns or 3D printed resin crowns.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

removal of caries from second primary molars reaching the pulp, pulpotomy will be done by controlling the bleeding after that pulp chamber will be covered with either MTA or endosequence bioceramic putty.

resin modified glass ionomer will be placed, crown preparation will be done to receive full coverage either stainless steel crowns or 3D printed resin crowns

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caries Active

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Endo-sequence bioceramic putty pulpotomy

Group Type EXPERIMENTAL

Endo-sequence bioceramic putty pulpotomy

Intervention Type PROCEDURE

* Profound local anesthesia and rubber dam isolation will be applied.
* Carious tissue will be completely removed using diamond burs until pulp exposure and deroofing.
* Coronal pulp will be removed with a sharp excavator.
* Hemostasis will be achieved with a saline-moistened cotton pellet for 5 minutes.
* Bioceramic putty applied directly from the manufacturer's syringe, then adapted gently with a moist cotton pellet.

Bio MTA+

Group Type ACTIVE_COMPARATOR

Bio MTA+ pulpotomy

Intervention Type PROCEDURE

* Profound local anesthesia and rubber dam isolation will be applied.
* Carious tissue will be completely removed using diamond burs until pulp exposure and deroofing.
* Coronal pulp will be removed with a sharp excavator.
* Hemostasis will be achieved with a saline-moistened cotton pellet for 5 minutes.
* The MTA powder will be mixed with the liquid to a putty consistency and applied with an amalgam carrier.

3D-printed ceramic-filled hybrid resin crowns

Group Type EXPERIMENTAL

3D-Printed Resin Crowns

Intervention Type DEVICE

* Tooth preparation: 1 mm axial reduction with a chamfer finish line using tapered diamond stone with round end (Mani TR-12) for buccal, lingual, mesial, and distal walls.
* One and half - 2 mm occlusal reduction.
* Digital impressions using IOS scanning, including occlusion and antagonist.
* 3D printed resin crowns will be designed using the Exocad software (Exocad Rigeka 3.1) to have a uniform thickness on all surfaces (average 1 mm), including occlusal, buccal, lingual, and proximal surfaces. After reviewing each design, it will be exported as a high-resolution STL file (standard tessellation language) to be outsourced and 3D printed.
* BEGO DLP printer will be utilized to print the crowns using VarseoSmile Trinique resin via digital light processing (DLP) technique.
* After printing, the platform will be removed from the 3D printer and placed on a paper towel with the printed crowns facing upward.
* The printed crowns will be separated from the platform and rinsed tw

Stainless steel crowns

Group Type ACTIVE_COMPARATOR

Stainless Steel Crowns (SSCs)

Intervention Type DEVICE

* Occlusal reduction of 1.0-1.5 mm using a flame-shaped diamond bur.
* Interproximal slicing to enable passive crown placement.
* Crown size selection based on best fit.
* Cementation using RMGIC.
* Excess cement will be removed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endo-sequence bioceramic putty pulpotomy

* Profound local anesthesia and rubber dam isolation will be applied.
* Carious tissue will be completely removed using diamond burs until pulp exposure and deroofing.
* Coronal pulp will be removed with a sharp excavator.
* Hemostasis will be achieved with a saline-moistened cotton pellet for 5 minutes.
* Bioceramic putty applied directly from the manufacturer's syringe, then adapted gently with a moist cotton pellet.

Intervention Type PROCEDURE

Bio MTA+ pulpotomy

* Profound local anesthesia and rubber dam isolation will be applied.
* Carious tissue will be completely removed using diamond burs until pulp exposure and deroofing.
* Coronal pulp will be removed with a sharp excavator.
* Hemostasis will be achieved with a saline-moistened cotton pellet for 5 minutes.
* The MTA powder will be mixed with the liquid to a putty consistency and applied with an amalgam carrier.

Intervention Type PROCEDURE

Stainless Steel Crowns (SSCs)

* Occlusal reduction of 1.0-1.5 mm using a flame-shaped diamond bur.
* Interproximal slicing to enable passive crown placement.
* Crown size selection based on best fit.
* Cementation using RMGIC.
* Excess cement will be removed.

Intervention Type DEVICE

3D-Printed Resin Crowns

* Tooth preparation: 1 mm axial reduction with a chamfer finish line using tapered diamond stone with round end (Mani TR-12) for buccal, lingual, mesial, and distal walls.
* One and half - 2 mm occlusal reduction.
* Digital impressions using IOS scanning, including occlusion and antagonist.
* 3D printed resin crowns will be designed using the Exocad software (Exocad Rigeka 3.1) to have a uniform thickness on all surfaces (average 1 mm), including occlusal, buccal, lingual, and proximal surfaces. After reviewing each design, it will be exported as a high-resolution STL file (standard tessellation language) to be outsourced and 3D printed.
* BEGO DLP printer will be utilized to print the crowns using VarseoSmile Trinique resin via digital light processing (DLP) technique.
* After printing, the platform will be removed from the 3D printer and placed on a paper towel with the printed crowns facing upward.
* The printed crowns will be separated from the platform and rinsed tw

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Deep carious second primary molars with:

1. Vital pulp confirmed by absence of clinical and/or radiographic signs of necorosis or infection.
2. Signs of reversible pulpitis. 10
2. Require full coverage restorations
3. Cooperative children (Frankl 3 or 4 behavior rating scale)

Exclusion Criteria

* History of spontaneous pain. 2. Tooth mobility. 3. Excessive bleeding from radicular stumps after coronal pulp amputation. 4. Radiographic evidence of pathological root resorption, inter-radicular bone loss, periapical pathology, or canal calcifications. 5. Previous dental treatment of the involved molar. 6. Children with special healthcare needs.
Minimum Eligible Age

5 Years

Maximum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alexandria University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yousr Nader

pediatric dentistry specialist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Dentistry, Alexandria University, Egypt

Alexandria, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

yousr nader pediatric dentist specialist, doctorate

Role: CONTACT

References

Explore related publications, articles, or registry entries linked to this study.

American Academy of Pediatric Dentistry. Pulp therapy for primary and immature permanent teeth Chicago (IL): American Academy of Pediatric Dentistry; 2023. 2. Abdelwahab DH KN, Badran AS, Darwish D, Abd El Geleel OM. Oneyear radiographic and clinical performance of bioactive materials in primary molar pulpotomy: A randomized controlled trial. J Dent 2024;143:104864. 3. Wang Z. Bioceramic materials in endodontics. Endod Topics 2015;32:3- 30. 4. Mahgoub N, Alqadasi B, Aldhorae K, Assiry A, Altawili ZM, Tao H. Comparison between iRoot BP Plus (EndoSequence Root Repair Material) and Mineral Trioxide Aggregate as Pulp-capping Agents: A Systematic Review. J Int Soc Prev Community Dent 2019;9:542-52. 5. Moazzami F, Sahebi S, Shirzadi S, Azadeh N. Comparative in vitro Assessment of Tooth Color Change under the Influence of Nano Fast Cement and MTA. J Dent (Shiraz) 2021;22:48-52. 6. Ayoub KM, Nagy MM, Aly RM, El Deen GN, El-Batouty K. Effect of Bio MTA plus & ProRoot MTA pulp capping materials on the regenerative properties of human dental pulp stem cells. Sci Rep 2025;15:4749. 7. Voicu G, Didilescu AC, Stoian AB, Dumitriu C, Greabu M, Andrei M. Mineralogical and Microstructural Characteristics of Two Dental Pulp Capping Materials. Materials (Basel) 2019;12:1772. 25 8. Kiranmayi T, Vemagiri CT, Rayala C, Chandrappa V, Bathula H, Challagulla A. In vivo comparison of bioceramic putty and mineral trioxide aggregate as pulpotomy medicament in primary molars. A 12- month follow-up randomized clinical trial. Dent Res J (Isfahan) 2022;19:84. 9. Alqahtani AS, Alsuhaibani NN, Sulimany AM, Bawazir OA. NeoPUTTY(®) Versus NeoMTA 2(®) as a Pulpotomy Medicament for Primary Molars: A Randomized Clinical Trial. Pediatr Dent 2023;45:240-4. 10. Arvelaiz C, Fernandes A, Graterol V, Gomez K, Gomez-Sosa JF, Caviedes-Bucheli J, et al. In Vitro Comparison of MTA and BC RRMFast Set Putty as Retrograde Filling Materials. Eur Endod J 2022;7:203- 9. 11. Motwani N, Ikhar A, Nikhade P, Chandak M, Rathi

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1155-10/2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

3Mixtatin and MTA Vital Pulpotomy in Primary Molars
NCT06478940 NOT_YET_RECRUITING PHASE1